Cellectis yog lub tuam txhab genome engineering tshwj xeeb hauv kev txhim kho cov tshuaj tiv thaiv kab mob. Cov nqi sib koom tau ua rau muaj kev txhawj xeeb nce mus txog ob peb xyoos dhau los, tshwj xeeb tshaj yog 12 lub hlis dhau los. Cov tub lag luam tab tom nug txog qhov yuav tsum tau yuav Cellectis shares.
CELLECTIS (ALCLS.PA) Qhia nqe hauv lub sijhawm
Tam sim no koj tuaj yeem yuav CELLECTIS Tshuag ntawm tus nqi ntawm € 4,57 ib feem. Txij li thaum pib ntawm hnub, ALCLS.PA tus nqi tau hloov los ntawm 6.6511164%.
Thaum qhib, CELLECTIS tus nqi yog € 4,32. Thaum lub sijhawm sib tham, qhov siab tau mus txog los ntawm tus nqi sib koom yog € 4,67 thaum qis tshaj yog € 4,26 thiab tus nqi kaw ntawm hnub yog € 4,29.
Yuav tsum koj yuav CELLECTIS shares - Cov duab tseem ceeb
[stock_market_widget type= »leaderboard » template= »basic » assets= »ALCLS.PA » realtime= »false » api= »yahoo-finance »]Tshaj li ib xyoos (52 lub lis piam dhau los) tus nqi ntawm CELLECTIS tau mus txog qhov siab ntawm € 4,84, thiab qhov qis tshaj mus txog 52 lub lis piam dhau los yog € 1,01.
[stock_market_widget type= »gauge » template= »basic » assets= »ALCLS.PA » low_high= »52_week_low_high » red_color= »#DB2828″ yellow_color= »#FBBD08″ green_color= »#21BA45″ animation_duration= »0″ api= »yahoo-finance »]Lub sijhawm 5 hnub ua lag luam dhau los ntawm CELLECTIS (ALCLS.PA) tus nqi tau hloov zuj zus raws li hauv qab no:
[stock_market_widget type= »table-history » template= »zebra4″ assets= »ALCLS.PA » fields= »date,open,high,low,close,volume » range= »5d » interval= »1d » pagination= »false » rows_per_page= »5″ sort_direction= »asc » alignment= »left » api= »yahoo-finance »]Koj yuav tsum yuav CELLECTIS shares thaum lub Kaum Ob Hlis?
Tam sim no tus nqi ntawm CELLECTIS yog € 4,57 thiab them nyiaj faib ntawm ib feem! CELLECTIS cov nyiaj faib tawm tus nqi yog % hauv ib xyoos yog tias koj yuav CELLECTIS shares ntawm tus nqi tam sim no.
[stock_market_widget type= »key-value-table-companies » template= »basic » assets= »ALCLS.PA » fields= »logo_name,symbol,industry,sector,website,phone,employees_count,country,full_address » api= »yahoo-finance »]Kuj tseem xav txog kev xaiv tus broker uas muaj qhov zoo ntawm kev muab kev ua tiav rau yuav cov stocks los ntawm thoob plaws lub ntiaj teb no! Qhov no yuav tso cai rau koj kom diversify koj cov ntaub ntawv tom qab.
Kev pom zoo thiab Nqe Lub Hom Phiaj ntawm Cov Kws Tshawb Fawb ntawm CELLECTIS Shares
[stock_market_widget type= »list » template= »basic » color= »#000000″ assets= »ALCLS.PA » fields= »logo_name_symbol,recommendation_key,target_high_price,target_median_price,target_low_price,analyst_opinions » realtime= »false » api= »yahoo-finance »]CELLECTIS Share Dividend
CELLECTIS tsis tam sim no faib cov nyiaj faib tawm. Yog li ntawd, nws tsis tuaj yeem tsim cov nyiaj tau los passive tam sim no. Qhov no txhais tau hais tias cov Tshuag no tsuas yog muab cov peev txheej tau txais txiaj ntsig yog tias tus nqi nce yav tom ntej thiab rov muag dua ntawm tus nqi siab dua tus nqi yuav khoom.
[stock_market_widget type= »list » template= »basic » color= »#000000″ assets= »ALCLS.PA » fields= »logo_name_symbol,currency,ex_dividend_date,dividend_rate,dividend_yield,5_year_avg_dividend_yield,annual_dividend_rate,annual_dividend_yield » realtime= »false » api= »yahoo-finance »]CELLECTIS Shareholders
Nov yog cov tswv cuab tam sim no ntawm CELLECTIS lub tuam txhab:
- ASTRAZENECA PLC – 22,30%
- Bpi Kev Koom Tes SA / PRIVATE EQUITY / – 8,186%
- PFIZER, UA - 3,884%
- Pierre Bastid – 2,595%
- Baillie Gifford & Co. – 1,879%
- André Choulika – 1,388%
- David Sourdive – 1,370%
- Financière Arbevel SA – 0,1761%
- Saint Olive Gestion SNC – 0,1185%
- Sunny Asset Management SA – 0,1185%
Cov neeg sib tw ntawm lub tuam txhab CELLECTIS
Txawm hais tias cov neeg sib tw ncaj qha tuaj yeem sib txawv raws li kev tshwj xeeb thiab thaj chaw, ntawm no yog qee lub tuam txhab uas tuaj yeem suav tias muaj peev xwm sib tw rau CELLECTIS:
- CRISPR Kev Kho Mob: Lub tuam txhab Swiss no tshwj xeeb hauv kev siv CRISPR-Cas9 thev naus laus zis los tsim kho noob. CRISPR Therapeutics yog ib qho tseem ceeb hauv kev kho genome thiab tab tom txhim kho kev kho mob rau ntau yam kab mob caj ces thiab hematological.
- Editas Tshuaj: Raws li hauv Tebchaws Meskas, Editas Tshuaj kuj tau tsom mus rau kev siv CRISPR-Cas9 thev naus laus zis los tsim kho cov noob caj noob ces. Lawv ua haujlwm rau kev kho mob ntawm lub qhov muag, cov kab mob metabolic, thiab cov kab mob neurological.
- Intellia Kev Kho Mob: Lwm lub tuam txhab Asmeskas, Intellia Therapeutics, tshwj xeeb hauv kev kho noob siv CRISPR-Cas9 thev naus laus zis. Lawv tab tom txhim kho kev kho mob rau cov kab mob tsis tshua muaj caj ces nrog rau cov kab mob siab.
- Beam Therapeutics: Beam Therapeutics, tseem nyob hauv Tebchaws Meskas, sib txawv ntawm nws tus kheej los ntawm kev siv genome kho kom zoo raws li cov tub ntxhais CRISPR thev naus laus zis, tab sis nrog kev hloov kho tshwj xeeb rau cov phiaj xwm nucleotide.
- Sangamo Therapeutics: Lub tuam txhab Asmeskas no siv lub tshuab hloov kho genome sib txawv hu ua ZFN (Zinc Finger Nuclease) los tsim kho cov noob caj noob ces. Lawv tsom mus rau ntau yam kab mob, suav nrog cov kab mob tsis tshua muaj caj ces thiab kev tiv thaiv kab mob.
Cov tuam txhab no yog cov thawj coj hauv kev kho noob caj noob ces thiab kho genome, thiab lawv feem ntau sib tw los tsim kho cov kab mob zoo sib xws. Kev nce qib thev naus laus zis thiab kev kho mob ua tiav ntawm ib qho ntawm cov tuam txhab no tuaj yeem cuam tshuam Cellectis 'kev sib tw hauv kev ua lag luam.
Cov neeg siv khoom ntawm lub tuam txhab CELLECTIS
Cellectis cov neeg siv khoom feem ntau yog cov koom tes thiab koom tes hauv kev lag luam biopharmaceutical. Raws li Cellectis tsom mus rau kev txhim kho cov noob kev kho mob, nws cov neeg siv khoom tseem ceeb feem ntau suav nrog:
- Pharmaceutical Partners: Cellectis koom tes nrog cov tuam txhab tshuaj loj los tsim kho cov noob caj noob ces. Cov koom tes no tuaj yeem suav nrog cov tuam txhab xws li Pfizer, Servier, thiab lwm tus neeg tseem ceeb hauv kev lag luam tshuaj.
- Cov koom haum tshawb fawb: Cellectis kuj tseem tuaj yeem ua haujlwm nrog cov tsev kawm tshawb fawb thiab cov chaw kho mob los ua kev tshawb fawb thiab kev sim tshuaj rau nws cov khoom.
- Cov neeg muab kev pabcuam: Qee lub tuam txhab biotechnology tuaj yeem tawm ntawm lawv cov kev tshawb fawb thiab kev loj hlob, xws li kev tsim cov kab mob kab mob lossis lwm yam khoom uas xav tau rau kev kho noob. Hauv qhov no, Cellectis tuaj yeem yog tus neeg siv khoom ntawm cov chaw muab kev pabcuam no.
- Investors thiab shareholders: Txawm hais tias cov tub ua lag luam tsis yog cov neeg siv khoom hauv kev xav ib txwm muaj, lawv yog qhov tseem ceeb rau nyiaj txiag Cellectis 'kev tshawb fawb thiab kev tsim kho cov dej num. Cov tuam txhab lag luam, cov peev nyiaj lag luam thiab cov neeg ua lag luam uas yuav Cellectis shares yog li tseem muaj feem cuam tshuam rau lub tuam txhab.
Cov piv txwv no tsis yog tag nrho, thiab CELLECTIS cov npe neeg siv yuav txawv nyob ntawm nws cov tswv yim kev lag luam thiab kev loj hlob.
Vim li cas Invest in CELLECTIS Shares
Kev nqis peev hauv Cellectis Tshuag tuaj yeem txhawb nqa los ntawm ntau yam, tab sis nws yog ib qho tseem ceeb uas yuav tsum nco ntsoov tias txhua qhov kev nqis peev cuam tshuam nrog kev pheej hmoo thiab txhua tus neeg ua lag luam yuav tsum ua lawv tus kheej kev tshuaj xyuas thiab kev ntsuam xyuas ua ntej txiav txim siab. Nov yog qee qhov laj thawj vim li cas qee cov tub ua lag luam yuav xav txog Cellectis ua txoj hauv kev peev:
- Innovative technology: Cellectis yog lub tuam txhab biopharmaceutical tsom rau kev txhim kho cov tshuaj kho noob. Lawv txoj kev tsim kho tshiab siv genome kho kom raug thiab kho cov kab mob sib txawv, suav nrog qee hom mob qog noj ntshav thiab cov kab mob tsis tshua muaj caj ces. Cov thev naus laus zis no tuaj yeem pom tau tias muaj txiaj ntsig zoo vim tias nws muaj peev xwm hloov kho cov kab mob.
- Cov khoom portfolio: Cellectis muaj cov khoom lag luam hauv kev txhim kho uas suav nrog ntau yam kev kho mob. Qhov no suav nrog kev kho mob qog noj ntshav, kab mob hematological, thiab kab mob tsis tshua muaj caj ces. Ib qho kev sib txawv portfolio tuaj yeem muab qee qhov kev hloov pauv rau kev lag luam.
- Strategic Partnerships: Cellectis tau tsim kev koom tes nrog ntau lub tuam txhab tshuaj loj, uas tuaj yeem muab cov txiaj ntsig zoo ntawm cov nyiaj txiag, kev sib koom tes tshawb fawb, thiab kev nkag mus rau cov peev txheej thiab kev lag luam. Piv txwv li, Cellectis muaj kev koom tes nrog Pfizer los tsim kho CAR-T.
- Kev loj hlob muaj peev xwm: Zoo li txhua lub tuam txhab biopharmaceutical tsom rau kev tshawb fawb thiab kev tsim kho, Cellectis muaj peev xwm loj hlob yog tias nws cov khoom lag luam hauv kev loj hlob tiav mus txog kev lag luam thiab hais txog cov kev xav tau kev kho mob tsis zoo.
Kev nqis peev hauv ib qho khoom lag luam tshwj xeeb xws li CELLECTIS yuav tsum muaj kev tshawb fawb tob thiab nkag siab txog cov kev pheej hmoo thiab cov hauv kev cuam tshuam nrog lub tuam txhab tshwj xeeb.
Koj tuaj yeem nqis peev hauv Cellectis shares ntawm Euronext Paris Nasdaq Ntiaj Teb Xaiv Kev Lag Luam (Invest Nasdaq).
